Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy.

Front Oncol · 2020 · PMC7550759 · PMID 33117699

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost reached statistical significanceno p-value reported

16.2 months (95% CI 6.8 – 25.6) for patients with pneumonitis ≥ grade 2; p 0.047]; landmark analysis at 1 month almost reached statistical significance for better OS in patients without pneumonitis ≥ grade 2 when compared with patients that developed pneumonitis ≥ grade 2 [median OS 22.4 months (95% CI 14.9 – 29.8) vs. 12.4 months (95% CI 5.5 – 19.4); p = 0.057], ( Supplementary Figure 1 ).

also in 378 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.